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We combined components of a previous assay referred to as Molecular Inversion Probe (MIP) with a complete gap filling
strategy, creating a versatile powerful one-primer multiplex amplification system. As a proof-of-concept, this novel method,
which employs a Connector Inversion Probe (CIPer), was tested as a genetic tool for pathogen diagnosis, typing, and antibiotic
resistance screening with two distinct systems: i) a conserved sequence primer system for genotyping Human Papillomavirus
(HPV), a cancer-associated viral agent and ii) screening for antibiotic resistance mutations in the bacterial pathogen Neisseria
gonorrhoeae. We also discuss future applications and advances of the CIPer technology such as integration with digital
amplification and next-generation sequencing methods. Furthermore, we introduce the concept of two-dimension
informational barcodes, i.e. ‘‘multiplex multiplexing padlocks’’ (MMPs). For the readers’ convenience, we also provide an
on-line tutorial with user-interface software application CIP creator 1.0.1, for custom probe generation from virtually any new
or established primer-pairs.
Citation: Akhras MS, Unemo M, Thiyagarajan S, Nyre ´n P, Davis RW, et al (2007) Connector Inversion Probe Technology: A Powerful One-Primer
Multiplex DNA Amplification System for Numerous Scientific Applications. PLoS ONE 2(9): e915. doi:10.1371/journal.pone.0000915
INTRODUCTION
Since the introduction of PCR [1], a vast variety of offspring
technologies have been engineered, continuously expanding
our molecular toolbox [2]. One such technique was multiplex
PCR [3], which allows for multiple reactions to occur in a single-
tube. Multiplex PCR offers clear benefits in clinical manage-
ment with respect to cost, time, sample need and contamination
risk [4].
Recent advances in multiplex PCR technology have been
significant [5–7]. Ligase Chain Reaction (LCR), an alternative
method of DNA amplification, uses a thermostable ligase for target
amplification [8]. In Gap-LCR [9], a thermostable polymerase is
also used, and dNTPs are included to allow for gap filling of the
flanking primers, mimicking nature’s Okazaki fragments [10]. The
padlock probe [11] introduced a novel concept of using a one-
primer system for DNA target detection, based on ligase probe
circularization and Rolling Circle Amplification (RCA) [12,13].
The Molecular Inversion Probe (MIP) [14], a more advanced
version of the padlock probe, contained also i) a molecular barcode
for downstream chip detection, ii) a single base gap that enables
single nucleotide polymorphism (SNP) detection, and iii) an
exponential amplification strategy based on probe inversion and
universal primer PCR amplification. MIP has since proved
suitable as an ultra high-throughput method [15], showing
potential for use in allele quantification [16] and pathogen
diagnostics [17,18].
We describe here a novel method, using a Connector Inversion
Probe (CIPer), which combines the gap fill strategy of Gap-LCR
with the structure of a padlock probe, creating a one-primer
amplification with complete gap filling properties (Figure 1). PCR,
a highly selective method, offers two degrees of selectivity, due to
the use of two primers. CIPer technology uses only one primer, but
retains two degrees of selectivity, owing to its dual detection; the
target homologous extension site (ES) and anchor site (AS). CIPer
also uses universal primer amplification in a one-protocol-fits-all
fashion, which circumvents the need for primer-specific thermo-
profiles. As a proof-of-concept, we tested CIPer on pathogen
recognition with two distinct systems: i) conserved sequence
primer genotyping of the cancer-associated viral agent Human
Papillomavirus (HPV) [19,20], and ii) a duplex amplification
of two genes prone to mutations and strongly linked with
resistance to key antibiotics (e.g. ciprofloxacin), in the bacterial
pathogen Neisseria gonorrhoeae [21–23]. Previously developed
Pyrosequencing protocols [24–26] were used for downstream
sequence validation.
Here we introduce the design and development of CIPer as well
as apply it with a robust protocol on viral and bacterial genetic
diagnostics, typing and antibiotic resistance screening. We also
provide an on-line tutorial with the user-interface software
application CIP creator 1.0.1, for probe generation from virtually
any primer pair (http://bioel.stanford.edu/CIPer).
Academic Editor: Neil Hall, University of Liverpool, United Kingdom
Received July 19, 2007; Accepted August 20, 2007; Published September 19,
2007
Copyright:  2007 Akhras et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This study was supported by a grant from National Institutes of Health
(PO1-HG000205). Michael S. Akhras was supported by Hans Werthe ´n Foundation;
Sixten Gemze ´us Scholarship Foundation; The Foundation Blanceflor Boncom-
pagni-Ludovisi, nee ´ Bildt; and the The Fulbright Commission.
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: pourmand@stanford.
edu
PLoS ONE | www.plosone.org 1 September 2007 | Issue 9 | e915RESULTS AND DISCUSSION
Connector Inversion Probe (CIPer) Design and
Performance
The Connector Inversion Probe (CIPer) reaction (Figure 1) shares
some basic design features with a recently described assay, the
PathogenMip assay [17], which includes: i) probe hybridization,
single ‘‘G’’ base gap fill and probe circularization, ii) exonuclease
based circular DNA selection, iii) probe inversion by re-
linearization, and iv) universal PCR amplification. The distin-
guishing and key feature of the CIPer method is a modified first
reaction step involving a complete filling of an extensive gap
formed by the probe and target (Figure 1B).
The 39end of the probe, which we call the Extension Site (ES),
primes for polymerization, while the 59end serves as point of
ligation and is referred to as the Anchor Site (AS) (Figure 1). With
all four dNTPs present, the polymerase is capable of extending
past the intended point of ligation, generating a false negative. To
address this problem, probes were designed to have an annealing
temperature of approximately 5 degrees higher for the AS than
that of the ES. The AS therefore blocks DNA extension when
using a polymerase deficient in strand displacement at an
appropriate intermediate temperature (50uC).
For enhanced sensitivity and specificity a vast variety of probe
concentrations and thermoprofiles were explored. Probes used in
the 10–100 fmol concentration range yielded the strongest signal.
Higher cycle numbers and shorter annealing times created a more
efficient thermoprofile. The CIPer method successfully genotyped
1 pg of plasmid DNA in the presence of 200 ng non-reacting
human genomic DNA, without generating any false positives
(Figure S1). Assay optimizations were based on genotyping of
HPV plasmid 56, validated by either SYBR GREEN assay or
agarose gel electrophoresis, followed by Pyrosequencing verifica-
tion (see Results, The Conserved Sequence Primer Connector Inversion Probe
(CSP-CIPer)).
The Conserved Sequence Primer Connector
Inversion Probe (CSP-CIPer)
The HPV CIPer (CSP-CIPer) was modeled on the primer-pair,
GP5+/6+ [27], and exemplifies the use of conserved sequence
primer (CSP) amplification. HPV genotyping is conventionally
performed with a nested PCR [28]. The interest here lies in the
detection potential of the CIPer compared with one-step PCR,
and therefore the nested PCR strategy was not a suitable
comparator for the model. The purpose of the CSP-CIPer was
initially to genotype HPV plasmids -16 and -18, which produced
amplicons visualized as agarose gel-bands at the expected size
range of 185-188 base pairs and correctly validated with
Pyrosequencing (Figure S2). With an accessible collection of 57
plasmids, a CSP-CIPer screen was performed in parallel with
conventional GP5+/6+ PCR. All amplicons were validated as
described in the Sentinel-base DNA genotyping method [25].
Among the non-detectable HPV genotypes were plasmids
encoding HPV-6, -11, -27, -28, -34, -39, -40, -44 and -73. These
genotypes all required a C-base instead of a T-base in the third
position from the ES 39end (Figure 2 and Figure S3). A degenerate
CSP-CIPer was constructed with a mixed ‘‘Y’’ base (C+T) at the
position of interest. The degenerate CSP-CIPer recognized and
genotyped 35 plasmids, while the GP5+/6+ PCR genotyped 38
plasmids (Table 1). Successful target amplification schemes appear
to be different for CIPers than for PCR primers; the success of
a PCR primer-pair is highly dependent on the conservation of the
3’ends [29], while for the CIPer the anchor site seems more
dependent upon annealing temperature. With the degenerate
probe, detection rates improved by 15%. With proper mathemat-
ical modeling of aligned regions, higher detection success can be
achieved with the use of degenerate bases or inosine residues [30].
To investigate the multiplexing strength of the CSP-CIPer,
mixtures of 1-8 plasmids (encoding HPV-16, -18, -33, -35, -39,
-45, -58 and -59) were made to mimic multiple co-infections, as
these are known to occur. The GP5+/6+ primers could genotype
Figure 1. Schematic overview of Connector Inversion Probe (CIPer) technology. A) Synthetic oligonucleotide containing regions i) AS and ES
(anchor site and extension sites): approximately 20 base pair fragments homologous to regions flanking target of interest, ii) R: restriction site for
probe linearization, iii) U1 and U2: universal primer regions for inverted probe amplification. B) Target rescue through complete gap filling by a DNA
polymerase and ligation-based probe circularization. C) Circular DNA enrichment through degradation of linear DNA by enzymes Exonuclease I and
III, which are deactivated prior to the next step. D) Probe linearization by restriction site cleavage. E) Inverted probes are amplified with universal
primers; one is biotinylated for subsequent amplicon validation. F) Amplicon validation using multiple sequencing primers.
doi:10.1371/journal.pone.0000915.g001
Connector Inversion Probe
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mixture, while the CSP-CIPer could genotype all eight plasmids
(Figure S4). The CSP-CIPer showed a 50% improved discrimi-
natory power over that of the GP5+/6+ PCR. Differences in target
amplification strategy account for this improvement. That is, PCR
is based on target-dependent amplification, while the CIPer is
based on target dependent probe circularization, followed by non-
target dependent universal amplification (Figure 1).
Antibiotic Resistance Mutation Screening
CIPer detection was also applied to screening of resistance
mutations in Neisseria gonorrhoeae. Two CIPers were used to perform
a duplex amplification in a single-tube of the genes gyrA and parC
[23], which are known to mutate easily and by specific SNPs
generate resistance to ciprofloxacin and other quinolone anti-
biotics. The CIPers were designed with CIP creator 1.0.1 (http://
bioel.stanford.edu/CIPer) based on previously described PCR
primer-pairs not originally intended for multiplex PCR [21]. We
intentionally inverted the gyrA CIPer to target the negative strand,
while the parC CIPer targeted the positive strand, to illustrate that
CIPers can be used on both DNA strands. In the case of close
target proximities, it might be wise to revise such a strategy.
Mutations on amino acid residues S91 and D95 for gyrA, and E91
for parC were the particular subjects of our interrogation. There
are many other candidate genes for future CIPer-based epidemi-
ological studies of antibiotic resistance [31].
Thirty-one Neisseria gonorrhoeae DNA extracts were screened in
parallel with the CIPers in a single-tube reaction, and conventional
PCR was performed in separate tubes for the two genes. Results
from CIPer and PCR were in 100% agreement. In gyrA, eight wild
type strains, three strains with double mutations resulting in amino
acid alterations S91P and D95A, ten strains with double mutations
resulting in S91P and D95G, eight strains with single mutation
S91P, and two strains with single mutation D95N were observed.
In parC, thirty wild type strains, and one strain with an E91G
mutation was observed (Figure 3).
Applications and Advances in Connector Inversion
Probe (CIPer) Technology
Connector Inversion Probe (CIPer) technology is a powerful
method for multiplex amplification, and has been validated here in
genetic pathogen diagnostics, typing, and antibiotic resistance
detection arenas as a proof-of-concept. This technology can be
designed and optimized for use in numerous other scientific areas
and applications. Other areas suitable for use of the CIPer method
include cancer genomics [32], human SNP detection [15], and
selective exon amplification [7], among numerous other promising
applications. Modified CIPers may also in the future offer an
alternative strategy for gateway cloning [33]. In this paper, we
focused on ‘‘lowplex’’ systems amplifying shorter stretches of DNA
of up to 100 base pair lengths. To achieve higher degrees of
multiplexing and longer clone reads, one must take into account i)
clone GC content, ii) clone length variability, and iii) steric effects
for longer clones.
Analog amplification and downstream validation are delimiting
factors for multiplex detection methods. We believe that the future
of CIPer technology will rely on digital amplification [34] and high
throughput sequencing validation (Figure S5). The CIPers
universal primer sites can be formatted to fit any amplification
method, e.g. RCA [12,13], emulsion PCR [34], SPIA [35] LAMP
[36] and SMAP 2 [37]; universal adaptor ligation, a tedious and
sample-consuming procedure [38], is therefore optional. Proposed
digital amplification methods include emulsion PCR, RCA, or
a combination of the two [39]. Suitable upcoming high
throughput validation methods include next-generation sequence
systems such as the 454 Life Sciences platform [38] (http://www.
454.com), the Solexa platform [40] (http://www.illumina.com),
polony sequencing [41] (http://www.agentcourt.com), Helicos
Figure 2. Sequence alignments (WebLogos, http://weblogo.berkeley.edu/logo.cgi) of the positive strand containing conserved sequence primer
regions for GP5+/6+. The height of a DNA-base height represents the relative abundance of that particular base at the position of interest; multiple
bases at the same position indicate a variable site. Alignment was performed for 40 genotypes detected with the CSP-CIPer or GP5+/6+ PCR (Table 1
and Figure S3). The target region between the two primers varies between 90-100 base pairs, depending on genotype characteristics. The positive
strand of the GP6+ region is the complementary sequence of the established primer, and is therefore denoted cGP6+.
doi:10.1371/journal.pone.0000915.g002
Table 1. Genotyping data from CSP-CIPer and GP5+/6+ PCR parallel screens.
..................................................................................................................................................
Method: CIPer and PCR (40 genotypes) CIPer only (2 genotypes) PCR only (5 genotypes)
Undetected by either method
(17 genotypes)
HPV-type 6b, 10, 11, 16, 18, 26, 27, 28, 29, 32, 33,
34, 35, 39, 40, 42, 44, 45, 52, 53, 54, 56,
58, 59, 62, 66, 67, 69, 70, 71, 72, 73, 74,
81, 82, 84, 86, 89, 90 and 91
27 and 29 28, 53, 71, 72 and 82 9, 12, 14, 15, 17, 19, 20, 21, 22, 23,
24, 36, 49, 50, 92, 93 and 96
HPV plasmids for 57 genotypes were used for testing and comparisons between the two systems. CSP-CIPer detected 35 plasmids, GP5+/6+ detected 38 plasmids, and
17 genotypes were not detected by either method. CSP-CIPer exclusively detected genotypes HPV-27 and -29, while GP5+/6+ PCR exclusively detected genotypes HPV-
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quencing array (GeneChip CustomSeq, www.affymetrix.com).
Recent digital quantification methods [43] open the possibility for
quantitative CIPer technology.
With the addition of a molecular barcode to the padlocks [14],
MIPs were used for ultra high-throughput SNP detection based on
microarray barcode hybridization [15]. Because CIPers can also
include a barcode, they could be used for microarray validation, or
amplicon tracing with sequencing methods [17,44] allowing for
longer read lengths [38]. With the introduction of a third universal
sequence flanking the barcode and the universal primer sites, one
can begin to envision a two-dimension informational barcode,
a concept we call ‘‘multiplexing multiplex padlocks’’ (MMP)
(Figure S6). Probe construction based on ligation of three smaller
constructs [45] would allow for variability in fragment assembly.
By combining the one-genotype detection pair of AS/ES
constructs with multiple unique barcodes, we can create patient
and genotype specific probes with one barcode per probe. This
will allow for analysis of multiple parallel samples, essentially
lowering the cost of microarray chips and sequencing reactions.
MATERIALS AND METHODS
DNA Materials
Oligonucleotides used in the assay (Table S1) were produced by
IDT technologies (Coralville, IA) and melting temperatures were
calculated using SciTools (IDT technologies). HPV plasmids were
kindly provided by Dr. E. M. de Villiers (DKFZ; Heidelberg,
Germany) HPV-6B, -11, -16, -18, -26, -27, -40, -45, -53, -72 and
-73; HPV-9, -10, -12, -14, -15, -17, -19, -20, -21, -22, -23, -24, -28,
-29, -32, -33, -34, -36, -39, -42, -49, -50, -54, -66, -70 and -74 by
Dr. M. Favre (Institute Pasteur; Paris, France); HPV-35, -44 and
-56 by Dr. A. Lorincz (Digene Corporation; Gaithersburg, MD);
HPV-58, -59, -67, -69, -71, -81 and -82 by Dr. T. Matsukura
(National Institute of Health; Tokyo, Japan); HPV-52 by Dr. W.
Lancaster (Wayne State University School of Medicine; Detroit,
MI); HPV-62, -84, -cand86, -cand89, -90 and -91 by Dr. R. D.
Burk (Albert Einstein College of Medicine of Yeshiva University,
Bronx, NY); HPV-92, -93 and -96 by Dr. O. Forslund (UMAS;
Malmo ¨ University Hospital, Malmo ¨, Sweden). All HPV plasmids
were normalized at 100 ng/ml( 615%) using a ND-100 Spectro-
photometer (NanoDrop, Wilmington, DE). Neisseria gonorrhoeae
DNA had been previously extracted [24]. Commercially available
human genomic DNA G3041 (Promega, Madison, WI) was used
for assay evaluation.
Connector Inversion Probe Assay
CIPer reactions were performed as follows: i) 100 ng of HPV
plasmid DNA or Neisseria gonorrhoeae DNA extract, 10 fmol each of
probe, 0.25 units Ampligase (Epicenter Biotechnologies, Madison,
WI), 0.25 mM of each dNTP (Fermentas, Hanover, MD), and 0.5
units AmpliTaq DNA Polymerase Stoffel Fragment (Applied
Biosystems, Foster City, CA) in 1X Ampligase buffer (Epicenter
Biotechnologies, Madison, WI) were combined in a total volume of
10 ml/reaction. After pre-incubation at 95uC for 10 min, the
reaction went through 99 cycles of 95uC for 2 min, 50uC for 5 min
and 37uC for 2 min. ii) 10 ml of 130 mM Tris-HCl (pH 7.8),
85.75 mM KCl, 3.85 mM MgCl2 and 0.1% BSA solution
containing 5.6 units Exonuclease I and 112 units Exonuclease
III (Epicenter Biotechnologies, Madison, WI) was added to each
reaction. The mixture was incubated at 37uC for 60 min followed
by enzyme deactivation at 80uC for 20 min. iii) 4 units of Uracil-
DNA-Glycosylase (New England BioLabs, Ipswich, MA) was
Figure 3. Pyrograms of Connector Inversion Probes (CIPer) used for screening of mutations conferring antibiotic (ciprofloxacin) resistance of
Neisseria gonorrhoeae strains. Amino acid codons are marked alternating blue and orange, and their positions in the coded amino acid sequence of
the target enzymes (GyrA and ParC) are placed on top of the traces. Codons marked in red are known to be subject to mutations, which are strongly
correlated with ciprofloxacin resistance [21–23]. The gyrA and parC mutant sequences are compared with the respective wild type sequences. The
displayed pyrograms show two common mutations (S91P and D95G) in gyrA, and one mutation (E91G) in parC.
doi:10.1371/journal.pone.0000915.g003
Connector Inversion Probe
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by enzyme deactivation at 80uC for 20 min. iv) PCR amplifica-
tion was carried out in a total reaction volume of 50 ml, containing
5 ml CIPer reaction, 1X PCR Buffer II (Applied Biosystems, Foster
City, CA), 2.5 mM MgCl2 (Applied Biosystems, Foster City, CA),
0.12 mM dNTPs (Fermentas, Hanover, MD), 2.5 units AmpliTaq
Gold DNA polymerase (Applied Biosystems, Foster City, CA) and
0.2 mM of each universal primer B-NP-F and NP-R (Table S1). A
10-min incubation step at 95uC was followed by 40 cycles of
amplification with a thermocycler GeneAmp PCR system 9700
(Applied Biosystems, Foster City, CA). Each cycle included
a denaturation step at 95uC for 45 sec, an annealing step at
52uC for 30 sec, and an extension step at 72uC for 30 sec. A final
extension was done at 72uC for 5 min. Real-time PCR reactions
were performed with the same thermoprofile on an Mx3005P
system (Stratagene, La Jolla, CA), with a SYBR green PCR master
mix (Applied Biosystems, Foster City, CA). Gel electrophoresis was
performed on a Sub-Cell Gt Agarose Electrophoresis System (Bio-
Rad, Hercules, CA) using a 2.5% agarose gel GenePure LE Quick
Dissolve (ISC Bioexpress, Kaysville, UT) with 5 mg/ml ethidium
bromide (Sigma-Aldrich, St. Louis, MO) staining.
Pyrosequencing
Single strand template preparation was performed as previously
described [26]. GP5+ and Sentinel-base sequencing primers were
used to screen all HPV CSP-CIPer clones and GYRA2-4 and
PARC-3 sequencing primers were used for Neisseria gonorrhoeae
CIPer clones (Table S1). Pyrosequencing was performed with
a cyclic de novo sequencing dispensation (ACGT) using a PSQ
TM
HS96A DNA sequencing system (Biotage, Uppsala, Sweden).
SUPPORTING INFORMATION
Figure S1 Agarose gel stained with ethidium bromide for CSP-
CIPer detection limit of HPV -56 in presence of human genomic
DNA. The plasmid concentration was varied, ranging from 10 ng
to 100 fg per reaction at a constant background of 200 ng non-
HPV-contaminated human genomic DNA. The minimum de-
tectable amount of HPV observed was 1 pg, and the 100 fg
mixture showed no significant amplification. The upper triangular
graph represents a visual interpretation of CIPer amplicon
intensity as a function of plasmid concentration, and the lower
graph the background intensity as a function of plasmid
concentration.
Found at: doi:10.1371/journal.pone.0000915.s001 (0.06 MB
PDF)
Figure S2 Agarose gel stained with ethidium bromide for
fragment size determination and pyrograms for HPV genotypes
-16 and -18. Amplicon sizes appear in the expected size of 185
base pairs for HPV-16 and 188 base pairs for HPV-18. The
negative controls for the CIPer reaction (‘‘CIPer-’’) and PCR
(‘‘PCR-’’) show no significant amplification. Pyrograms derived
from multiple sequencing primers MSP-16 and MSP-18 (Table
S1) validate the expected sequence.
Found at: doi:10.1371/journal.pone.0000915.s002 (0.21 MB
PDF)
Figure S3 Genomic regions GP5+/6+ aligned for 40 genotypes
detected by either CSP-CIPer or GP5+/6+ PCR (Table 1).
Alignment was performed and displayed with ClustalX (http://
www.biodirectory.com/biowiki/ClustalX). The targeted region
flanking the two primers varies between 90-100 base pairs
depending on genotype characteristics, and is represented in the
figure with three Ns.
Found at: doi:10.1371/journal.pone.0000915.s003 (0.30 MB
PDF)
Figure S4 Detecting multiple HPV co-infections. In order to
compare the discriminative power of the CIPer vs. PCR detection,
artificial mixtures of the eight plasmids HPV-16, -18, -33, -35, -39,
-45, -58 and -59 were constructed to ‘‘mimic’’ real-case multiple
co-infections. The CIPer method could detect all eight genotypes
present in the same sample, while PCR managed with the four
genotypes HPV-16, -18, -33 and -45. As seen in the figure the
Pyrogram intensities vary for different genotypes, indicating
a lower discriminative preference for certain types. Among the
four PCR detected genotypes, HPV-16 and -33 showed very weak
diagrams and were barely detectable in the presence of the
preferred genotypes -18 and -45. CIPer detection suffered to
a lesser degree of such preferred selectivity, as all types were clearly
distinguishable. We believe that differences in target amplification
strategy account for this improvement, i.e. PCR is based on target
dependent amplification, while the CIPer is based on target
dependent probe circularization, followed by non-target depen-
dent universal amplification.
Found at: doi:10.1371/journal.pone.0000915.s004 (0.64 MB
PDF)
Figure S5 Digital amplification strategies prior to probes
validation. A) Emulsion based PCR; adapters are optional since
CIPers already contain universal segments flanking the target of
interest. The technology involves the inclusion of DNA and
a primed magnetic bead in mineral oil (an emulsion), which allows
for single molecule amplifications. Suitable upcoming methods for
downstream sequence validation include the 454 Life Sciences
platform (http://www.454.com), the Solexa platform (http://
www.illumina.com), polony sequencing (http://www.agentcourt.
com), Helicos Biosciences (http://www.helicosbio.com), or use of
a resequencing array (GeneChip CustomSeq, www.affymetrix.
com). B) Rolling circle amplification (RCA) with single-molecule
detection (SMD). Digital quantification combines RCA and SMD
in form of fluorescent-labeled target specific oligonucleotides. The
amplified CIPers can be quantified using microfluidic analysis and
visualized with a microscope for ultimate levels of quantification.
The number of available fluorescent labels limits the degree of
multiplexing.
Found at: doi:10.1371/journal.pone.0000915.s005 (0.06 MB
PDF)
Figure S6 ‘‘Multiplex multiplexing padlocks’’ (MMP) construct
assembly for CIPer probes production. The extended CIPer
carries a third universal segment and flanks the barcode together
with the other universal segments. The probe is divided and
synthesized in three constructs, with the middle one containing the
barcode. Through a two-way ligation scheme the three fragments
can be joined into a full-length probe. Following the grid-like
assembly strategy displayed in the figure, one-genotype detection
pair of AS/ES constructs is combined with multiple unique
barcodes. The unique barcode now carries two dimensions of
information, i.e. genotype and patient ID. Post-reaction CIPers
can be combined into multiple patient pools and all screened
simultaneously, essentially lowering costs involved with down-
stream validations, both for hybridization-based techniques and
sequencing procedures.
Found at: doi:10.1371/journal.pone.0000915.s006 (0.05 MB
PDF)
Table S1 Oligonucleotides used in the present study. Bold italic
marked sequences in the anchor sites of CIPers -gyrA and +parC
were added to the originally described primers [21] to obtain
Connector Inversion Probe
PLoS ONE | www.plosone.org 5 September 2007 | Issue 9 | e915higher annealing temperature values for the anchor site. The
number in parenthesis following the multiple sequencing primers
(MSPs) denotes which primer pool the MSP belongs to.
Found at: doi:10.1371/journal.pone.0000915.s007 (0.09 MB
PDF)
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